BioSpace News Archive

Biotech Bay

Mirvie Receives FDA Breakthrough Device Designation for First Test Designed to Indicate Risk of Preeclampsia Months Before Symptoms Occur

Mirvie, a pioneer in predicting unexpected pregnancy complications, today announced the company received U.S. Food and Drug Administration (FDA) Breakthrough Device designation for its test to indicate a woman’s individualized risk of developing preeclampsia before symptoms occur.

May 3, 2022
·
5 min read
Pharm Country

Petros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company’s Novel Topical Investigational Treatment for Peyronie’s Disease

Petros Pharmaceuticals, Inc. announces today they will be pursuing the 505(b)(2) pathway for its investigational agent, H-100™, a novel, patented, non-invasive topical treatment being developed for Peyronie’s disease, a condition impacting more than 1 in 10 men in the US.

May 3, 2022
·
7 min read
BioMidwest

Centene to Present at Bank of America 2022 Healthcare Conference

Centene Corporation announced it will present at the Bank of America 2022 Healthcare Conference, to be held Monday, May 9-Friday, May 13, 2022, in Las Vegas.

May 3, 2022
·
1 min read
Drug Development

Topline Data for Dazodalibep (HZN-4920) Meets Primary Endpoint in Rheumatoid Arthritis

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that its Phase 2, randomized, double-blinded, placebo-controlled trial of dazodalibep (HZN-4920) in rheumatoid arthritis (RA) met the primary endpoint.

May 3, 2022
·
4 min read
Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration

Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today the company has advanced into its Good Laboratory Practice (GLP) toxicology study.

May 3, 2022
·
3 min read
Lone Star Bio

Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas

Matica Biotechnology, Inc. announced the opening of its new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.

May 3, 2022
·
2 min read
Pharm Country

Parkinson’s Foundation Announces Major Expansion of PD GENEration Study, Increasing Access to Genetic Testing and Counseling Across the U.S.

The Parkinson’s Foundation has announced the expansion of PD GENEration: Mapping the Future of Parkinson’s Disease, a first-of-its-kind national initiative offering genetic testing and counseling for people with Parkinson’s disease (PD) at no cost.

May 3, 2022
·
4 min read
Business

Dr. Nidal Huniti joins A2PG as President

A2PG and Amador Bioscience announced that Dr. Nidal Huniti has joined the company as President of A2PG.

May 3, 2022
·
3 min read
Lytix Biopharma to host Capital Markets Day - June 1, 2022

Lytix Biopharma is pleased to announce that it will host a Capital Markets Day for investors, analysts and media on Wednesday, June 1, 2022

May 3, 2022
·
1 min read
Pharm Country

Tevogen Bio Expands Research and Development Capacity at CIC Philadelphia to Accommodate its Expanding Product Portfolio

Tevogen Bio, today announced new laboratory space has been secured at CIC Philadelphia to facilitate the company’s rapid expansion of its R&D, process development, and analytical capabilities to allow for further advancement of its next generation precision T cell technology programs.

May 3, 2022
·
5 min read